These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2983723)

  • 1. Sialic acid moiety is responsible for the charge heterogeneity and the biological potency of rat lutropin.
    Hattori M; Ozawa K; Wakabayashi K
    Biochem Biophys Res Commun; 1985 Mar; 127(2):501-8. PubMed ID: 2983723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different profiles of isoelectric avian luteinizing hormone components in biological activity and immunoreactivity.
    Hattori M; Wakabayashi K
    Endocrinol Jpn; 1983 Aug; 30(4):551-60. PubMed ID: 6323153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of subunit sialic acid in the thyrotropic and gonadotropic activities of human chorionic gonadotropin.
    Amir SM; Kasagi K; Ingbar SH
    Endocrinology; 1987 Jul; 121(1):160-6. PubMed ID: 3036467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoelectric properties, lectin binding characteristics and biological activities of neuraminidase-treated rat LH components.
    Hattori M; Ozawa K; Wakabayashi K
    Acta Endocrinol (Copenh); 1988 Jan; 117(1):73-9. PubMed ID: 3381629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sialic acid residues in the in vitro superactivity of human choriogonadotropin (hCG) in rat Leydig cells.
    Apparailly F; Combarnous Y
    Biochim Biophys Acta; 1994 Dec; 1224(3):559-65. PubMed ID: 7803516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of human luteinizing hormone. Effect of neuraminidase treatment on biologically active hormone and alpha- and beta-subunits.
    van Ginkel LA; Loeber JG
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):577-83. PubMed ID: 3577588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of human pituitary lutropin (LH). Effect of the seven isohormones on mouse Leydig cell functions.
    Lichtenberg V; Weise HC; Graesslin D; Bettendorf G
    FEBS Lett; 1984 Apr; 169(1):21-4. PubMed ID: 6325236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of desialylated human chorionic gonadotropin (hCG) on the bioactivity of rat Leydig cells.
    Ronco AM; Tijmes M; Santibáñez JF; Moraga P
    Cell Biochem Funct; 1998 Mar; 16(1):21-8. PubMed ID: 9580152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of human pituitary lutropin (LH). Isolation and partial characterization of seven isohormones.
    Weise HC; Graesslin D; Lichtenberg V; Rinne G
    FEBS Lett; 1983 Aug; 159(1-2):93-6. PubMed ID: 6873306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on rat ovarian receptors for lutropin (luteinizing hormone). Interaction with beta-subunit of sheep lutropin.
    Muralidhar K; Moudgal NR
    Biochem J; 1976 Dec; 160(3):615-9. PubMed ID: 189756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo bioactivities and clearance patterns of highly purified human luteinizing hormone isoforms.
    Burgon PG; Stanton PG; Robertson DM
    Endocrinology; 1996 Nov; 137(11):4827-36. PubMed ID: 8895353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of LH components having different ratios of bioactivity to immunoreactivity in the rat pituitary glands.
    Hattori M; Sakamoto K; Wakabayashi K
    Endocrinol Jpn; 1983 Jun; 30(3):289-96. PubMed ID: 6662068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of luteinizing-hormone-receptors and steroidogenesis in the neonatal rat testis.
    Huhtaniemi IT; Katikineni M; Catt KJ
    Endocrinology; 1981 Aug; 109(2):588-95. PubMed ID: 6265192
    [No Abstract]   [Full Text] [Related]  

  • 14. Desensitization of tumour Leydig cells by lutropin: evidence for uncoupling of the lutropin receptor from the guanine nucleotide-binding protein.
    Dix CJ; Schumacher M; Cooke BA
    Biochem J; 1982 Mar; 202(3):739-45. PubMed ID: 6284136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the carbohydrate moiety of the rat ovarian luteinizing-hormone/chorionic-gonadotropin receptor for ligand-binding specificity and signal transduction.
    Petäjä-Repo UE; Merz WE; Rajaniemi HJ
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):839-44. PubMed ID: 8318013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor binding, biological, and immunological properties of chemically deglycosylated pituitary lutropin.
    Sairam MR; Schiller PW
    Arch Biochem Biophys; 1979 Oct; 197(1):294-301. PubMed ID: 232401
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct interaction of the sialic acid residue of human lutropin and chorionic gonadotropin with target cell is necessary for the full expression of their hormonal action.
    Amano J; Kobata A
    Arch Biochem Biophys; 1993 Sep; 305(2):618-21. PubMed ID: 8396895
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
    Dirami G; Cooke BA
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human luteinizing hormone. Structure and function of some preparations.
    Loeber JG
    Acta Endocrinol Suppl (Copenh); 1977; 210():3-130. PubMed ID: 194451
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of human luteinizing hormone. Discrimination between acidic and basic preparations.
    van Ginkel LA; Loeber JG
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):73-82. PubMed ID: 2741642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.